http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
호흡기 알레르기 환자에서 혼합항원 추출액을 이용한 면역요법의 효과 및 그 예측 지표
강문수 ( Kang Mun Su ),최영환 ( Choe Yeong Hwan ),허영구 ( Heo Yeong Gu ),김항재 ( Kim Hang Jae ),김능수 ( Kim Neung Su ) 대한내과학회 1992 대한내과학회지 Vol.42 No.3
The study was undertaken in 217 multi-allergen sensitive allergy patients (126 cases of asthma, 91 of rhinitis) ranging in age from 5 to 64 years to investigate the effect of immunotherapy and to find parameters that might predict the efficacy of specific immunotherapy. All the patients, who had received a subcutaneous standard immunotherapy for more than 12 months, was grouped into response groups and no response group by symptom-medication scoring system. Various parameters including patients`s age, duration of symptom, serum IgE level, RAST score and lymphocyte subsets as well as pulmonary function were compared between groups. The efficacy of better than poor response of specific immunotherapy was found in 130 patients (60%), 74 (58.7%) in asthma and 56 (61.5%) in rhinitis, among the 217 allergy patients, and the immunotherapy with mixedallergen extracts including house dust mites was appeared to be more effective than in only house dust mite immunotherapy. There showed lower mean age and higher T-cell count in good/excellent response group of total allergy patients. In asthma patients, the good/excellent group showed lower mean age of patients and higher FEV1 levels. However, short duration of symptom was the only parameter to predict good/excellent response in rhinitis patients. These results suggest that patient`s age, duration of symptom, kinds of allergens and pulmonary function should be considered in predicting the efficacy of immunotherpy with mixed-allergen extracts in respiratory allergy patients.